Literature DB >> 19945621

Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.

Hye Jin Chung1, Jouni Uitto.   

Abstract

Type VII collagen is a major component of the anchoring fibrils of the dermal-epidermal adhesion on the dermal side at the lamina densa/papillary dermis interface. Dystrophic epidermolysis bullosa (DEB) emerged as a candidate for type VII collagen mutations becausing anchoring fibrils were shown to be morphologically altered, reduced in number, or completely absent in patients with different forms of DEB. Circulating autoantibodies recognize type VII collagen epitopes in epidermolysis bullosa acquisita. The suggestion that type VII collagen is required for human epidermal tumorigenesis relates to the increasing numbers of life-threatening complications associated with developing squamous cell carcinomas because of the extended life span of affected individuals with recessive DEB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19945621      PMCID: PMC2791403          DOI: 10.1016/j.det.2009.10.011

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  43 in total

1.  Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs.

Authors:  Claus-Werner Franzke; Kaisa Tasanen; Heike Schäcke; Zhongjun Zhou; Karl Tryggvason; Cornelia Mauch; Paola Zigrino; Susan Sunnarborg; David C Lee; Falk Fahrenholz; Leena Bruckner-Tuderman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 2.  Molecular diagnosis of inherited skin diseases: the paradigm of dystrophic epidermolysis bullosa.

Authors:  A M Christiano; J Uitto
Journal:  Adv Dermatol       Date:  1996

3.  Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin.

Authors:  M Chen; M P Marinkovich; A Veis; X Cai; C N Rao; E A O'Toole; D T Woodley
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

Review 4.  Type VII collagen, anchoring fibrils, and epidermolysis bullosa.

Authors:  R E Burgeson
Journal:  J Invest Dermatol       Date:  1993-09       Impact factor: 8.551

5.  Cloning of mouse type VII collagen reveals evolutionary conservation of functional protein domains and genomic organization.

Authors:  S Kivirikko; K Li; A M Christiano; J Uitto
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

6.  Procollagen VII self-assembly depends on site-specific interactions and is promoted by cleavage of the NC2 domain with procollagen C-proteinase.

Authors:  Morgana Colombo; Raymond J Brittingham; John F Klement; Ireneusz Majsterek; David E Birk; Jouni Uitto; Andrzej Fertala
Journal:  Biochemistry       Date:  2003-10-07       Impact factor: 3.162

7.  Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

Authors:  J C Lapiere; D T Woodley; M G Parente; T Iwasaki; K C Wynn; A M Christiano; J Uitto
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.

Authors:  D T Woodley; R A Briggaman; E J O'Keefe; A O Inman; L L Queen; W R Gammon
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

9.  Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms.

Authors:  A M Christiano; D S Greenspan; S Lee; J Uitto
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

Review 10.  Collagens, modifying enzymes and their mutations in humans, flies and worms.

Authors:  Johanna Myllyharju; Kari I Kivirikko
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

View more
  47 in total

1.  High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.

Authors:  Tobias Kühl; Markus Mezger; Ingrid Hausser; Rupert Handgretinger; Leena Bruckner-Tuderman; Alexander Nyström
Journal:  Mol Ther       Date:  2015-04-10       Impact factor: 11.454

Review 2.  Minor collagens of the skin with not so minor functions.

Authors:  Georgios Theocharidis; John T Connelly
Journal:  J Anat       Date:  2017-02-02       Impact factor: 2.610

3.  Electro-optical Synergy Technique: A New and Effective Nonablative Approach to Skin Aging.

Authors:  Moetaz El-Domyati; Tarek S El-Ammawi; Walid Medhat; Osama Moawad; My G Mahoney; Jouni Uitto
Journal:  J Clin Aesthet Dermatol       Date:  2010-12

4.  Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.

Authors:  Satoru Shinkuma; Zongyou Guo; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-03       Impact factor: 11.205

5.  Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes.

Authors:  Kerstin Thriene; Björn Andreas Grüning; Olivier Bornert; Anika Erxleben; Juna Leppert; Ioannis Athanasiou; Ekkehard Weber; Dimitra Kiritsi; Alexander Nyström; Thomas Reinheckel; Rolf Backofen; Cristina Has; Leena Bruckner-Tuderman; Jörn Dengjel
Journal:  Mol Cell Proteomics       Date:  2018-01-11       Impact factor: 5.911

Review 6.  Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.

Authors:  Michael Vanden Oever; Kirk Twaroski; Mark J Osborn; John E Wagner; Jakub Tolar
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

7.  Toward treatment and cure of epidermolysis bullosa.

Authors:  Jouni Uitto
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-11       Impact factor: 11.205

Review 8.  Next generation human skin constructs as advanced tools for drug development.

Authors:  H E Abaci; Zongyou Guo; Yanne Doucet; Joanna Jacków; Angela Christiano
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-07

Review 9.  Novel molecular therapies for heritable skin disorders.

Authors:  Jouni Uitto; Angela M Christiano; W H Irwin McLean; John A McGrath
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

Review 10.  Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies.

Authors:  Luis Soro; Cynthia Bartus; Stephen Purcell
Journal:  J Clin Aesthet Dermatol       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.